Celldex Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $398.1M | $25.3M |
| Jun 2022 | — | $365.1M | $28.4M |
| Sep 2022 | — | $345.4M | $18.6M |
| Dec 2022 | — | $326.2M | $29.4M |
| Mar 2023 | — | $302.7M | $54.1M |
| Jun 2023 | — | $277.5M | $28.2M |
| Sep 2023 | — | $246.7M | $21.1M |
| Dec 2023 | — | $429.2M | $34.8M |
| Mar 2024 | — | $838.6M | $115.1M |
| Jun 2024 | — | $813.7M | $42.7M |
| Sep 2024 | — | $785.9M | $36.4M |
| Dec 2024 | — | $747.0M | $28.4M |
| Mar 2025 | — | $703.0M | $17.1M |
| Jun 2025 | — | $655.4M | $23.0M |
| Sep 2025 | — | $598.4M | $36.0M |
| Dec 2025 | — | $527.2M | $28.9M |
| Mar 2026 | — | $456.2M | $35.7M |
| Jun 2026 | — | $714.6M | $47.5M |